CrystalsFirst GmbH

[Available On-Demand]
Search General Info
Search Education
Search Partnering Companies
Title: Disrupting the access to structural data for exploration of the vast chemical space

Successful and efficient access to chemical matter in early drug discovery is increasingly becoming bottleneck. Projects stagnate, underperform and milestones are not reached.

CrystalsFirst’s platform overcomes these challenges by disrupting the structural biology process and opening new doors to vast chemical space.
CrystalsFirst’s hybrid platform reveals real binders on a structural level and enables the exploration of billions of drug-likes.
Company Type:
Company Website:
Company HQ State:
Not Provided
Company HQ Country:
Germany
Year Founded:
2018
Main Therapeutic Focus:
Lead Product in Development:
-
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
photo
CEO
CrystalsFirst GmbH